Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAVALIER Trial: Calcium and Vasopressin in Hemorrhagic Shock
NCT05958342Phase 2Recruiting
- Start
- Jun 2024
- Primary completion
- Mar 2027
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of calcium gluconate, vasopressin in hemorrhagic shock, psychological trauma. Started Jun 2024; status: recruiting.
02
Drugs
calcium gluconatevasopressin
03
Conditions
hemorrhagic shockpsychological trauma
Beyond the preview
Go deeper on NCT05958342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05958342.